Walleye Trading
EDIT icon

Walleye Trading’s Editas Medicine EDIT Stock Holding History

Walleye Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117,100
Closed -$240K – 4269
2025
Q4 		$240K Buy
117,100
+111,100
+1,852% +$321K ﹤0.01% 3294
2025
Q3 		$20.8K Buy
+6,000
New +$16.7K ﹤0.01% 4127
2023
Q3 		– Sell
-9,100
Closed -$74.9K – 5063
2023
Q2 		$74.9K Sell
9,100
-45,100
-83% -$393K ﹤0.01% 3848
2023
Q1 		$393K Sell
54,200
-263,700
-83% -$2.34M ﹤0.01% 2991
2022
Q4 		$2.82M Sell
317,900
-65,000
-17% -$714K 0.01% 1451
2022
Q3 		$4.69M Buy
382,900
+64,500
+20% +$1.01M 0.01% 1073
2022
Q2 		$3.77M Sell
318,400
-22,400
-7% -$300K 0.01% 1199
2022
Q1 		$6.48M Buy
340,800
+328,500
+2,671% +$6.11M 0.02% 849
2021
Q4 		$327K Sell
12,300
-10,600
-46% -$365K ﹤0.01% 3412
2021
Q3 		$941K Buy
22,900
+10,800
+89% +$592K ﹤0.01% 2266
2021
Q2 		$685K Sell
12,100
-3,300
-21% -$122K ﹤0.01% 2545
2021
Q1 		$647K Buy
15,400
+9,400
+157% +$536K ﹤0.01% 2355
2020
Q4 		$421K Buy
6,000
+2,800
+88% +$115K ﹤0.01% 2829
2020
Q3 		$90K Sell
3,200
-4,100
-56% -$134K ﹤0.01% 3440
2020
Q2 		$216K Buy
+7,300
New +$191K ﹤0.01% 3013
2020
Q1 		– Sell
-4,400
Closed -$130K – 4100
2019
Q4 		$130K Sell
4,400
-5,700
-56% -$142K ﹤0.01% 3427
2019
Q3 		$230K Sell
10,100
-12,900
-56% -$320K ﹤0.01% 2824
2019
Q2 		$569K Buy
23,000
+15,600
+211% +$372K ﹤0.01% 2095
2019
Q1 		$181K Sell
7,400
-52,700
-88% -$1.19M ﹤0.01% 3103
2018
Q4 		$1.37M Buy
60,100
+39,000
+185% +$1.06M 0.01% 1392
2018
Q3 		$671K Sell
21,100
-8,000
-27% -$259K ﹤0.01% 2548
2018
Q2 		$1.04M Sell
29,100
-19,600
-40% -$694K 0.01% 2055
2018
Q1 		$1.61M Buy
+48,700
New +$1.74M 0.01% 1425

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Trading's EDIT Position: Q1 2024 in Review

Walleye Trading sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 29,828 shares — an estimated $302K sold.

Walleye Trading first reported a position in EDIT in Q1 2018 and held it in 18 quarters. The position peaked at $1.56M in Q2 2021. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Walleye Trading reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 29,828 Editas Medicine shares in Q1 2024, an estimated $302K.
  • Walleye Trading first reported a position in Editas Medicine in Q1 2018 and held it in 18 quarters.
  • Walleye Trading's Editas Medicine position peaked at $1.56M in Q2 2021.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.